ISSN: 2642-1143
Authors: AA Mamun SM*, Islam QT, Sarker SU and Mannan S
The SARS-CoV-2 virus causes the illness COVID-19, which may lead to mild to severe respiratory problems. These symptoms are more severe in people with chronic obstructive pulmonary disease (COPD) have a higher risk of more severe illness from COVID-19 due to their existing lung problems. Based on our existing knowledge, Experience of last one year & meta analysis of different study report, this review has taken the initiative to find the answer of few key question: Firstly is the COPD patient have increased risk of Covid19. Secondly, do systemic corticosteroids offer protection against COVID-19 with COPD or not? And, finally, what is the evidence regarding use of MDI or Nebulization & NIV as standard treatment. This up-to-date review will make scope for some of the key issues which have significant impact on the long-term outlook for COPD patients in the context of COVID-19.
Keywords: COVID-19; COPD; NIV
